chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up with even more swelling but into my ankles/The joint pain has gotten worse. Now it's in both arms from just below the elbows into the fingers. And both legs from my knees into my feet.; I could hardly walk; very painful stinging; hardly being able to breathe; Blood pressure has also been very high; headache; Pain in joints; swelling in wrists and fingers; racing heart; pain and pressure from fingers to shoulder; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 52-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACINE, Solution for injection, Batch/Lot Number: W0178), via an unspecified route of administration, administered in Arm Right on 05Jun2021 12:00 (Age at vaccination: 52-years-old) as single dose for covid-19 immunization. Medical history included fibromyalgia, obesity, spondylitis grade 3 all from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. patient did not receive any other vaccine within four weeks. Patient was not diagnosed with covid-19 prior to vaccination. It was reported that within 10 mins of shot on 05jun2021 swelling in wrists and fingers. Pain in joints, headache, racing heart, pain and pressure from fingers to shoulder. As of Monday 10Jun2021 she woke up with even more swelling but into her ankles which were so severe she could hardly walk, also very painful stinging. The joint pain has gotten worse. Now it in both arms from just below the elbows into the fingers. And both legs from her knees into her feet. This was constant swelling and pain. Also woke up to hardly being able to breathe. And still having headaches. Blood pressure has also been very high as well since the covid vaccine. Adverse events resulted In Doctor or other healthcare professional office/clinic visit. Since the vaccination patient was not tested with covid-19. The patient underwent lab tests and procedures which included blood pressure measurement: very high on 10Jun2021. Therapeutic measures were taken as a result of events with Lasix. The outcome for the events was reported as not resolved at the time of this report.   Follow-up (19Jul2021): Follow-up attempts completed. No further information expected.  Follow-up (04Aug2021): Follow-up attempts completed. No further information expected.
SHE HAD ARM PAIN AFTER THE SHOT FOR SEVERAL DAYS BUT THAT SUBSIDED. SHE SAID 3 DAYS AFTER THE SHOT SHE STARTED HAVING INFLAMMATION, SWELLING, WARMTH ON HER INJECTED ARM.
On Saturday my stomach started being upset and I ended up with diarrhea. I had diarrhea for 3 days. It ended on Monday. I was kind of weak and a little disoriented. I would lose balance when standing up. I was feeling bad in general. I went to the ER, and they diagnosed me with strep throat and being dehydrated. They gave me antibiotics and IV. They did blood work, COVID-19 test, flu test, strep throat test, and x-rays. Everything came back negative except for the strep throat test.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 9:16 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 9:16 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 77.24  Concomitant products were not provided.  On 11-Jan-2021, Excursion time was 02 PM, temperature was 35, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 08-Jan-2021, vial was moved to clinic on 11-Jan-2021. 09 vials were sent to clinic. Vaccine BUD date was 07-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
I have noticed frequent Charlie horses in my legs, once in my hip, since I have received the vaccination.  I had these during my pregnancies years ago, but rarely ever outside of that.  I didn?t think anything of the Charlie horses in relation to the vaccine until a friend asked me if I was getting leg cramps after the vaccination too.  Yesterday, another friend said she was having the same issue since vaccination.  Today, another friend said she was having the same issue.  This seems like more than a coincidence.  Last night I woke up out of a deep sleep with a horrible leg cramp.  It is still sore today.  I feel strongly this is related to the vaccine. I?d still choose the vaccine over COVID-19 any day, but wanted to inform you of another possible side effect.
Pt in for 2nd COVID vaccine states walked a long way and did not eat breakfast.  After vaccine felt dizzy and faint she was put on the floor and when she felt better V/S done B/P 116/83, O2, 99%, Temp 97.7, pulse 80.  First aid rendered ice pack and Trendelenburg position. Once she felt better we gave her a bag of cookies and water.  Rideshare ride given to family so she would not have to walk home.
pt recv vax;redness in upper arm around inject site;rash on abd & back;no hx of prior rxn;to hlth ctr;pt did not appear to be in any physical distress;
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroid" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION, start date: May1991; SYNTHROID, start date: Aug1994. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid from 14Feb2023 to 18Feb2023).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Drug ineffective/got COVID; Suspected COVID-19/got COVID; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Clumsy" (unspecified if ongoing); "Double vision" (unspecified if ongoing); "Limp" (unspecified if ongoing); "Trouble walking" (unspecified if ongoing). Concomitant medication(s) included: OCREVUS; RITUXAN. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Drug ineffective/got COVID"; SUSPECTED COVID-19 (medically significant), outcome "unknown", described as "Suspected COVID-19/got COVID".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300091292 Same patient/same product, different dose/event;
Broke out holiday weekend; Rash; Nauseated for about 1-2 days after 1st shot/Nauseated holiday weekend; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Broke out holiday weekend), RASH (Rash) and NAUSEA (Nauseated for about 1-2 days after 1st shot/Nauseated holiday weekend) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus-like syndrome.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Broke out holiday weekend), RASH (Rash) and NAUSEA (Nauseated for about 1-2 days after 1st shot/Nauseated holiday weekend). At the time of the report, ADVERSE DRUG REACTION (Broke out holiday weekend), RASH (Rash) and NAUSEA (Nauseated for about 1-2 days after 1st shot/Nauseated holiday weekend) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-080222 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Reporter details were reported On 20-Jul-2021: Follow-up received on 21-JUL-2021 and contains non significant information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080222:FIRST DOSE CASE
shortness of breath for 9days; Felt strange in my head for 2 days; Diarrhea; Flush; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 173), via an unspecified route of administration in the left arm on 04May2021 at 11:45 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, migraine and high cholesterol. The patient had a history of allergy to iodine dye. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) and herbal supplements (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04May2021, the patient experienced 3 very powerful weird sensations like a flush, shortness of breath for 9 days, diarrhea, the flush feeling had made the patient bend in half and take mask off and felt strange in head for 2 days. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events a flush, shortness of breath for 9 days, diarrhea and felt strange in head for 2 days were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Alopecia areata; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (prev dose lot unknown reason: Not available/not provided to the notifier at the time of completion of the report, DOSE 2, SINGLE), for COVID-19 immunization; Bnt162b2 (prev dose lot unknown reason: Not available/not provided to the notifier at the time of completion of the report, DOSE 1, SINGLE), for COVID-19 immunization. The following information was reported: ALOPECIA AREATA (non-serious) with onset 20Sep2021, outcome "unknown", described as "Alopecia areata". The event "alopecia areata" was evaluated at the physician office visit.  Additional information: The patient did not have any other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient was not tested COVID post vaccination.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose; during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose; during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 80-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number T4AP4, expiry date 26-MAR-2025) for prophylaxis.   On 10-NOV-2023, the patient received Arexvy. On 10-NOV-2023, an unknown time after receiving Arexvy, the patient experienced incomplete dose administered (Verbatim: during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose), inadvertent exposure to vaccine (Verbatim: during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose) and exposure via skin contact (Verbatim: during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose). The outcome of the incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact were unknown.  Additional Information: GSK Receipt Date: 10-NOV-2023 The pharmacist reported during administration of Arexvy, the needle leaked vaccine out onto the patient's arm and she did not get a full dose, which led to incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact. The reporter consented to follow up.
This spontaneous report was received from a 50 year old female patient who was also a pharmacist. The patient's pertinent medical history and drug Reactions/allergies were reported as none. Pharmacist reported that on unspecified dates in 2017, she had administered 4 doses of ZOSTAVAX (lot and expiry date not reported) (extra dose administered). Concomitant medications included flu vaccine, Hepatitis A vaccine (manufacturer unknown) and hepatitis B vaccine (manufacturer unknown). On an unspecified date, she began feeling muscle weakness, facial numbness, and sciatic leg pain on the right side of her body. Her primary physician referred her to an unspecified immunologist/allergist. On unspecified dates, she had received unspecified tests by the immunologist, starting 01-FEB-2018. Pharmacist reported that reaction subsided when she did not administer ZOSTAVAX. She also reported that it would take 6 months to a year for complete recovery. Outcome of the muscular weakness, hypoaesthesia and sciatica was recovering and their causality assessment was not reported.
Patient woke up with a hard knot at injection site, redness, and swelling. Doctor prescribed an antibiotic treatment.
Some achey-ness and a bit of chills.  Bad migraine with very frequent (every 20-30 seconds) bolts of very sharp pain in my head in addition to migraine.  This went on for 30 hours.  No treatment...just waited it out and used cool packs on head. Also had very enlarged tender nodes under my left arm which are going away.
This spontaneous report as received from a physician refers to a 5 years old patient of unknown gender. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. On 02-NOV-2017, the patient was vaccinated with the dose of ZOSTAVAX (lot #, expiration date, dose, schedule and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent. The patient did not experience any adverse event. The product quality complain (PQC) was not involved.
This is a spontaneous report received from a Pfizer-sponsored program. A female patient (reported herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Expiry date: Unknown), via an unspecified route of administration on 18Feb2021 at SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced cough tickling on her throat. The treatment included Benzonatate 100mg yesterday wants to know if that is safe given that she had 1st dose. The outcome of the event was Unknown. Information on the lot/batch number has been requested.
Pt received 1st dose of covid-19 vaccine during mass clinic. Pt was given 30 minute observation period due to history of allergic reaction to strawberries, which pt defined as tongue tingling. Approx 15 minutes into observation period, pt described feeling the same feeling of her tongue tingling with feeling slightly light-headed. Pt denied SOB, chest pain, itching. EMS evaluated pt and was not given any medication but instructed to take PO Benadryl once home and to call 911 if symptoms worsened. Her 4 Lead EKG was WNL. Pt left facility without issue though reported feeling "a little funny still" but denied feeling worse.
Patient reported to pharmacy about 1hour after receiving her Moderna vaccine.  Patient stated the was feeling itchy all over her body and was starting to get red splotches.  We gave her 25mg of diphenhydramine by oral route and she reported it was starting to resolve about 30 minutes later.
Site swollen, warm to the touch, and itches 1 day post administration. Prescribed AUGMENTIN. Rechecked on 11/1/14 - mild erythema, however no heat, non tender, remains indurated.
Narrative: 83yo male patient died on 9/9/2021 in ICU at non-agency hospital transferred from nursing home under agency contract. Pt had underwent surgery on 8/11/21 for dislocation of left artificial hip. Pt also under agency hemetology care for myeloproliferative neoplasmJAK2 positive. Pt also developed renal impairment prior to death. Pt had received covid vaccines on 1/26/21 & 2/23/21. This death is likely not related to the vaccinations due to comorbidities, ager, and length of time from vaccine administration.
presents with neuropathy since December 2017 from chemo with vaccination reaction. She had the shingles shot on May 6 th  And then 2 hours later she started getting pains in her legs . It was into her shins and feet . It's especially at night. The location of the pain is from the hips down . The quality of the pain is cramping and with paresthesia  ( since 2017 dec). The severity of the pain is 8/10.The onset of pain was approximately  6weeks ago. The timing of the pain is constant . The pain is worse with  nothing she can think of . The pain is made better with alleve twice a day , biofreeze .  She hasn't been able to do the gym or climb the stairs .  She walks up side step because of pain and weakness.
Severe itching and mild rash starting approximately 6 hours after injection.  Treated the first 12 hours with Benadryl. Mild itching still continues.
A few days after a sore shoulder from my second Moderna vaccine, I started itching at the site of injection which continues to this day. It also is slightly sore to the touch (nothing unbearable) right above my elbow. Is this normal after 2 months and how long will it continue?
Mentation has declined since hospital discharger for fall on 2/6/20201. Patient has also had significant poor oral intake. Brought in due to apneic episodes.  Abdominal pain - diffuse tenderness (right sided) Elevated liver enzymes - likely secondary to dehydration Increased serum creatine kinase - likely due to dehydration
The patient received the Pfizer booster shot in early January. She  then started to have heart rhythm issues. This is now under control and has been for about 2 months.
Pt seen in clinic 06/13/02 10:00 for well check. Given immunization fever stated at 20:00. Hallucinations started at 23:00 seeing bugs on the wall and water flowing. Fever of 103, vomiting. Emesis X1. Fever lasted for a few hours. Awaken at 0100 with hallucinations again seeing people grabbing her. Child had dose of Tylenol and Motrin earlier in evening. Pt taken to ER at 01:15, observed until 04:00 then dismissed.
CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 31 year old female. The patient's weight was 76.5 kilograms, and height was 168 centimeters. The patient's concurrent conditions included alcohol use 2 drinks per week, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and had no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: UNKNOWN) dose was not reported, administered on 01-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 02-MAY-2021, the subject experienced chills. On 02-MAY-2021, the subject experienced fever. On 02-MAY-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, and headache on 03-MAY-2021. This report was non-serious.
2 days after shot work up with red arm and spread in to near elbow,  itchy and warm     -  continue to wash with soap and water,  use of triamcinolone  to area
Red, itchy, watery, blood shot eyes, runny nose, cough, slight rubbing to upper L posterior lobe, scratchy throat. Pt trying to clear throat, headache with pressure behind eyes, stated she felt slightly confused, flushing to face, redness to ears, stated she felt hot and sweaty lasting 15-20 min. then was freezing x 30 min. Felt like she needed to have BM-this lasted from start to finish x 5 hours-with symptoms diminishing as time passed. Pt used ALBUTEROL inhaler x 1 but denied using other medical treatment even though she was told she was having allergic reaction.
This spontaneous prospective pregnancy report was received from a female patient of unknown age regarding herself. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck). The patient stated that she has discovered that she was pregnant currently after receiving VARIVAX (Merck). The patient explained that she received the vaccine during her menstrual period and believed that she conceived 2 weeks after vaccination. Additional information is not expected.
The patient said she experienced extreme pain and limited mobility the evening following her vaccinations which she received in the same arm.  # days later she was seen by a physician who diagnosed her with a bruised tendon.